ZLife Technologies
We have developed and patented a novel preservation solution to be used as a clinical treatment for ischemia-reperfusion injury in organ transplantation, particularly intestinal transplantation. Team: Ming Zhang, MD, PhD.…
Read MoreSynthis
Synthis is developing a novel immuno-oncology (IO) therapeutic that reserves immune suppression in metastatic melanoma patients who have failed immune checkpoint blockade. Team: Dori T. Karyat, Ph.D., Founder
Read MoreChemitope Glycopeptide
Chemitope specializes in the chemical synthesis of complex glycopeptides for use in challenging vaccine applications, such as HIV. Team: Baptiste Aussedat, PhD William Walkowicz, PhD
Read More